Representative before the EPO

Company dna rouse ip limited
no operation time available
3 offices
active in Legal Services

Representative before the EPO

Employment test 51 - 200 employees
Company dna kilburn and strode llp
operating since 1906
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 44 EP applications Dayle Anne Callaghan has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after December 06, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12747021

COMPOSITIONS AND METHODS FOR LEACH EXTRACTION OF MICROORGANISMS

IPC classification:
C12P 7/00
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Agent:
William Gerrit Arends, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP12811493

ROBOTIC SURGICAL DEVICES, SYSTEMS AND RELATED METHODS

IPC classification:
G05B 19/00, G05B 15/00
Applicant:
University of Nebraska
Agent:
Boult Wade Tennant Ltd
Agent:
David Michael Grant, Marks & Clerk
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
GRANT OF PATENT INTENDED
EP12772543

METHOD OF EXTRACTING LUTEIN/XANTHOPHYLLS FROM NATURAL MATERIALS AND HIGHLY PURIFIED LUTEIN/XANTHOPHYLLS OBTAINED FROM THE METHOD THEREOF

IPC classification:
C07C 403/24
Applicant:
Chulalongkorn University
Agent:
Cabinet Plasseraud
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
The patent has been granted
EP12708482

FUS1/TUSC2 THERAPIES

IPC classification:
A61K 48/00, G01N 33/00
Agent:
Boult Wade Tennant Ltd
Agent:
David Michael Grant, Marks & Clerk
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
PATENT GRANTED
EP11778722

SELF-LAUNCHING MOVABLE SCAFFOLDING SYSTEM

IPC classification:
E01D 21/00
Agent:
Cabinet Plasseraud
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
GRANT OF PATENT INTENDED
EP14165977

Improved neurturin molecules

IPC classification:
A61K 38/17, C07K 14/475, C07K 14/47, A61P 25/00
Agent:
Boult Wade Tennant Ltd
Agent:
David Michael Grant, Marks & Clerk
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
The patent has been granted
EP14179390

Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same

IPC classification:
A61K 47/44, A61K 47/14, A61K 47/12, A61K 31/568, A61K 9/48, A61K 9/107
Agent:
Boult Wade Tennant Ltd
Agent:
David Michael Grant, Marks & Clerk
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
The patent has been granted
EP13714069

SEPARATOME-BASED PROTEIN EXPRESSION AND PURIFICATION PLATFORM

IPC classification:
C12P 21/02, C12N 15/79, C12N 15/74, C12N 15/70, C12N 1/20
Applicant:
University of Arkansas
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Multiple attorneys, Kilburn & Strode LLP
Agent:
Marks & Clerk
Agent:
Multiple attorneys, Rouse IP Limited
Status:
EXAMINATION IN PROGRESS
EP13764829

SYSTEMS AND METHODS TO DETERMINE AND MONITOR CHANGES IN RAIL CONDITIONS

IPC classification:
G01N 29/00
Applicant:
University of Nebraska
Agent:
Boult Wade Tennant Ltd
Agent:
David Michael Grant, Marks & Clerk
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13733180

HIGH THROUGHPUT SEQUENCING OF MULTIPLE TRANSCRIPTS OF A SINGLE CELL

IPC classification:
C12Q 1/68
Agent:
Boult Wade Tennant Ltd
Agent:
David Michael Grant, Marks & Clerk
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
GRANT OF PATENT INTENDED
EP13806521

LOCAL CONTROL ROBOTIC SURGICAL DEVICES AND RELATED METHODS

IPC classification:
B25J 17/02, B25J 9/18, B25J 9/04
Applicant:
University of Nebraska
Agent:
Boult Wade Tennant Ltd
Agent:
David Michael Grant, Marks & Clerk
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
PATENT GRANTED
EP13731455

APPARATUS FOR CONVERTING ENERGY FROM FLUID FLOW

IPC classification:
F03B 13/08
Agent:
Multiple attorneys, Kilburn & Strode LLP
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
The patent has been granted
EP13823115

METHODS, SYSTEMS, AND DEVICES RELATING TO OPEN MICROFLUIDIC CHANNELS

IPC classification:
B81C 1/00, B81B 1/00
Agent:
Appleyard Lees Ltd
Agent:
Boult Wade Tennant Ltd
Agent:
David Michael Grant, Marks & Clerk
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
The patent has been granted
EP13828139

DIRECTIONAL ELUTING IMPLANTABLE MEDICAL DEVICE

IPC classification:
A61F 2/90, A61F 2/86, A61F 2/82
Agent:
Boult Wade Tennant Ltd
Agent:
David Michael Grant, Marks & Clerk
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13827790

ASCORBIC ACID-ELUTING IMPLANTABLE MEDICAL DEVICES, SYSTEMS, AND RELATED METHODS

IPC classification:
A61F 2/02
Agent:
Boult Wade Tennant Ltd
Agent:
David Michael Grant, Marks & Clerk
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
GRANT OF PATENT INTENDED
EP13827150

ROBOTIC SURGICAL DEVICES, SYSTEMS, AND RELATED METHODS

IPC classification:
A61B 1/313
Applicant:
University of Nebraska
Agent:
Boult Wade Tennant Ltd
Agent:
David Michael Grant, Marks & Clerk
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
GRANT OF PATENT INTENDED
EP13794617

A NOVEL TOXIN IN TYPE A CLOSTRIDIUM PERFRINGENS

IPC classification:
A61K 39/385, A61K 39/08, G01N 33/569, C12N 15/31, C07K 19/00, C07K 16/12, C07K 14/33, A61P 37/04, A61P 31/04
Applicant:
University of Guelph
Agent:
William Gerrit Arends, Marks & Clerk
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
GRANT OF PATENT INTENDED
EP13844604

GOLD RECOVERY FROM REFRACTORY ORES AND CONCENTRATES

IPC classification:
C22B 11/00, C22B 3/00
Agent:
Boult Wade Tennant Ltd
Agent:
Marks & Clerk
Agent:
Dayle Anne Callaghan, Rouse IP Limited
Status:
GRANT OF PATENT INTENDED
EP14756906

ALPHA-SYNUCLEIN ANTIBODIES AND USES THEREOF

IPC classification:
A61P 25/00, A61K 39/395, C07K 16/44
Applicant:
United Arab Emirates University
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Agent:
David Michael Grant, Marks & Clerk
Status:
EXAMINATION REQUESTED
EP14819728

SOFT TISSUE IMPLANT

IPC classification:
C12N 5/071, A61K 35/52, A01N 63/00
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP14817208

APPARATUS FOR HANGING DROP DETECTION OF EPIDURAL SPACE PENETRATION

IPC classification:
A61M 5/00
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP14747919

VESICLES

IPC classification:
A61K 8/67, A61K 8/14, A61Q 19/08, A61Q 17/04, A61K 8/55, A61K 8/06, A61K 8/02, A61K 9/107, A61K 9/127, A61K 9/00, A61K 47/24, A61K 47/48
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP14846151

E. COLI SEPARATOME-BASED PROTEIN EXPRESSION AND PURIFICATION PLATFORM

IPC classification:
C12P 21/02, C12N 15/79, C12N 15/74, C12N 15/70, C12N 1/20
Applicant:
University of Arkansas
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP14862987

MONOVALENT ANTIGEN BINDING CONSTRUCTS TARGETING EGFR AND/OR HER2 AND USES THEREOF

IPC classification:
A61K 39/00, C12N 5/07, C12P 21/06, C12P 21/08
Applicant:
Zymeworks Inc
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP14863869

USE OF FLUORINATED CYCLIC DINUCLEOTIDES AS ORAL VACCINE ADJUVANTS

IPC classification:
A61P 37/04, A61P 31/04, A61K 31/7084, A61K 39/39
Applicant:
Brock University
Applicant:
National Research Council of Canada
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP16153694

FORMULATIONS FOR LYSOSOMAL ENZYMES

IPC classification:
A61P 3/00, A61K 38/46, A61K 47/30, A61K 47/34, A61K 38/17, A61K 38/16
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP14821918

SYNERGISTIC BACTERIAL COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOF

IPC classification:
A61K 35/00, A61K 35/745, A61K 35/744, A61K 35/742
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP14866161

BISPECIFIC ANTIGEN-BINDING CONSTRUCTS TARGETING HER2

IPC classification:
C40B 40/08, C12N 5/10, C12N 15/13, C07K 16/28, A61P 35/00, A61K 47/48, A61K 39/395, C07K 16/46
Applicant:
Zymeworks Inc
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP13895342

CANCER TREATMENT WITH COMBINATION OF PLINABULIN AND TAXANE

IPC classification:
A61P 35/00, A61K 31/337, A61K 31/496
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP15749661

NOVEL FULL SPECTRUM ANTI-DENGUE ANTIBODY

IPC classification:
C07K 16/00, C12P 21/08, A61K 39/42, A61K 39/395
Applicant:
Massachusetts Institute of Technology (MIT) Inc.
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP15765060

CARBOXY-CYCLOPROPYL UNDECANOL COMPOUNDS FOR TREATMENT OF LIVER DISEASE AND OTHER MEDICAL DISORDERS

IPC classification:
A61P 31/18, A61P 31/12, A61P 1/16, A61K 31/194
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP15715386

TURBINE ASSEMBLY

IPC classification:
F03B 17/06, F03B 13/08
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP16190858

COMPOSITIONS FOR INFUSION OF TRANSIENTLY ENGRAFTING, SELECTED POPULATIONS OF ALLOGENEIC LYMPHOCYTES

IPC classification:
C12N 5/078, A61P 35/00, A61P 7/00, A61K 38/00
Applicant:
Johns Hopkins University
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
The patent has been granted
EP15793514

DEIMMUNIZED LYSOSTAPHIN AND METHODS OF USE

IPC classification:
A61P 31/04, A61K 38/48, C12N 9/52
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP15734226

MODIFIED LATENCY ASSOCIATED PROTEIN CONSTRUCT

IPC classification:
C12N 15/62, C07K 14/495
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED
EP14906044

COMPOUNDS FOR USE AS IMAGING AGENTS

IPC classification:
A61P 25/28, A61K 31/343, A61K 31/352, A61K 31/704, G01N 33/58
Applicant:
United Arab Emirates University
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
Request for examination was made
EP15881004

RVG DERIVED PEPTIDES

IPC classification:
A61P 25/28, A61K 47/50, A61K 47/42, C07K 7/06, C07K 14/145
Applicant:
United Arab Emirates University
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
Request for examination was made
EP16749903

USE OF PLINABULIN IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS

IPC classification:
A61P 35/00, A61K 39/395, A61K 31/496
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
Request for examination was made
EP16752906

ADOPTIVE CELL TRANSFER METHODS

IPC classification:
A61K 31/727
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
Request for examination was made
EP16752908

TREATMENT OF CANCERS AND HEMATOPOIETIC STEM CELL DISORDERS PRIVILEGED BY CXCL12-CXCR4 INTERACTION

IPC classification:
A61K 31/727
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
Request for examination was made
EP16762149

METHOD OF TREATING CANCER ASSOCIATED WITH A RAS MUTATION

IPC classification:
A61P 35/00, A61K 31/496
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
Request for examination was made
EP16762150

METHOD OF TREATING A BRAIN TUMOR

IPC classification:
A61P 35/00, A61K 31/496
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
Request for examination was made
EP16824996

PLINABULIN COMPOSITIONS

IPC classification:
C07D 403/06
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
Request for examination was made
EP16854098

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING INTELLECTUAL DISABILITIES

IPC classification:
G01N 33/50, G01N 33/48, G01N 33/68, A61P 25/28
Agent:
Dayle Anne Callaghan, Kilburn & Strode LLP
Status:
Request for examination was made

Please Sign in to use this feature